Imatinib-Induced Psoriasis

dc.contributor.authorAtalay, Figen
dc.contributor.authorKizilkilic, Ebru
dc.contributor.authorAda, R. Simin
dc.date.accessioned2024-07-12T21:57:44Z
dc.date.available2024-07-12T21:57:44Z
dc.date.issued2013en_US
dc.departmentMaltepe Üniversitesien_US
dc.description.abstracten_US
dc.identifier.doi10.4274/Tjh.2012.0147
dc.identifier.endpage218en_US
dc.identifier.issn1300-7777
dc.identifier.issue2en_US
dc.identifier.pmid24385791en_US
dc.identifier.scopus2-s2.0-84879140260en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage216en_US
dc.identifier.urihttps://dx.doi.org/10.4274/Tjh.2012.0147
dc.identifier.urihttps://hdl.handle.net/20.500.12415/8721
dc.identifier.volume30en_US
dc.identifier.wosWOS:000320972500022en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherGALENOS YAYINCILIKen_US
dc.relation.ispartofTURKISH JOURNAL OF HEMATOLOGYen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmzKY08959
dc.subjectChronic Myelogenous Leukemiaen_US
dc.subjectImatiniben_US
dc.subjectPsoriasisen_US
dc.titleImatinib-Induced Psoriasisen_US
dc.typeLetter
dspace.entity.typePublication

Dosyalar